Guangdong Marubi Biotechnology Co
Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company provides skin care, make up, and eye care products. It offers its products under the Marubi, Lianhuo, Haruji, and the Love Fire brand names. The company was founded in 2002 and is based in Guangzhou, China.
Guangdong Marubi Biotechnology Co (603983) - Net Assets
Latest net assets as of September 2025: CN¥3.39 Billion CNY
Based on the latest financial reports, Guangdong Marubi Biotechnology Co (603983) has net assets worth CN¥3.39 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.85 Billion) and total liabilities (CN¥1.46 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥3.39 Billion |
| % of Total Assets | 69.97% |
| Annual Growth Rate | 27.39% |
| 5-Year Change | 14.86% |
| 10-Year Change | 381.41% |
| Growth Volatility | 31.18 |
Guangdong Marubi Biotechnology Co - Net Assets Trend (2011–2024)
This chart illustrates how Guangdong Marubi Biotechnology Co's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Guangdong Marubi Biotechnology Co (2011–2024)
The table below shows the annual net assets of Guangdong Marubi Biotechnology Co from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥3.45 Billion | +0.82% |
| 2023-12-31 | CN¥3.42 Billion | +5.10% |
| 2022-12-31 | CN¥3.25 Billion | +2.98% |
| 2021-12-31 | CN¥3.16 Billion | +5.26% |
| 2020-12-31 | CN¥3.00 Billion | +12.39% |
| 2019-12-31 | CN¥2.67 Billion | +93.21% |
| 2018-12-31 | CN¥1.38 Billion | +43.95% |
| 2017-12-31 | CN¥959.96 Million | +15.92% |
| 2016-12-31 | CN¥828.09 Million | +15.67% |
| 2015-12-31 | CN¥715.92 Million | +18.43% |
| 2014-12-31 | CN¥604.48 Million | +33.41% |
| 2013-12-31 | CN¥453.11 Million | +92.92% |
| 2012-12-31 | CN¥234.87 Million | +58.68% |
| 2011-12-31 | CN¥148.02 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Guangdong Marubi Biotechnology Co's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1962.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥2.02 Billion | 59.73% |
| Common Stock | CN¥401.00 Million | 11.86% |
| Other Components | CN¥960.20 Million | 28.40% |
| Total Equity | CN¥3.38 Billion | 100.00% |
Guangdong Marubi Biotechnology Co Competitors by Market Cap
The table below lists competitors of Guangdong Marubi Biotechnology Co ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Claros Mortgage Trust Inc
NYSE:CMTG
|
$288.08 Million |
|
Signature Bank
PINK:SBNYL
|
$288.11 Million |
|
Yduqs Participações S.A
SA:YDUQ3
|
$288.17 Million |
|
Hap Seng Consolidated Bhd
KLSE:3034
|
$288.24 Million |
|
J&V Energy Tech Co Ltd
TW:6869
|
$287.88 Million |
|
Shenzhen King Explorer Science and Technology Corp Class A
SHE:002917
|
$287.87 Million |
|
Newgen Software Technologies Limited
NSE:NEWGEN
|
$287.80 Million |
|
Jiangsu New Energy Development Co Ltd
SHG:603693
|
$287.79 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Guangdong Marubi Biotechnology Co's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,347,129,838 to 3,380,406,892, a change of 33,277,054 (1.0%).
- Net income of 341,628,712 contributed positively to equity growth.
- Dividend payments of 313,155,277 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥341.63 Million | +10.11% |
| Dividends Paid | CN¥313.16 Million | -9.26% |
| Other Changes | CN¥4.80 Million | +0.14% |
| Total Change | CN¥- | 0.99% |
Book Value vs Market Value Analysis
This analysis compares Guangdong Marubi Biotechnology Co's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.26x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 74.69x to 3.26x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | CN¥0.37 | CN¥27.44 | x |
| 2012-12-31 | CN¥0.62 | CN¥27.44 | x |
| 2013-12-31 | CN¥1.26 | CN¥27.44 | x |
| 2014-12-31 | CN¥1.67 | CN¥27.44 | x |
| 2015-12-31 | CN¥1.98 | CN¥27.44 | x |
| 2016-12-31 | CN¥2.28 | CN¥27.44 | x |
| 2017-12-31 | CN¥2.68 | CN¥27.44 | x |
| 2018-12-31 | CN¥3.81 | CN¥27.44 | x |
| 2019-12-31 | CN¥6.66 | CN¥27.44 | x |
| 2020-12-31 | CN¥7.43 | CN¥27.44 | x |
| 2021-12-31 | CN¥7.69 | CN¥27.44 | x |
| 2022-12-31 | CN¥7.95 | CN¥27.44 | x |
| 2023-12-31 | CN¥8.39 | CN¥27.44 | x |
| 2024-12-31 | CN¥8.41 | CN¥27.44 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Guangdong Marubi Biotechnology Co utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.11%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.50%
- • Asset Turnover: 0.59x
- • Equity Multiplier: 1.50x
- Recent ROE (10.11%) is below the historical average (34.46%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 113.31% | 27.28% | 1.03x | 4.04x | CN¥152.50 Million |
| 2012 | 79.69% | 22.93% | 1.16x | 3.01x | CN¥163.43 Million |
| 2013 | 48.25% | 22.45% | 1.04x | 2.07x | CN¥173.30 Million |
| 2014 | 44.89% | 25.23% | 0.89x | 1.99x | CN¥210.93 Million |
| 2015 | 39.31% | 23.63% | 0.87x | 1.91x | CN¥209.84 Million |
| 2016 | 28.04% | 19.22% | 0.82x | 1.78x | CN¥149.38 Million |
| 2017 | 32.49% | 23.07% | 0.84x | 1.67x | CN¥215.92 Million |
| 2018 | 30.20% | 26.35% | 0.74x | 1.54x | CN¥277.76 Million |
| 2019 | 19.28% | 28.59% | 0.52x | 1.29x | CN¥247.90 Million |
| 2020 | 15.60% | 26.61% | 0.46x | 1.27x | CN¥166.62 Million |
| 2021 | 8.04% | 13.87% | 0.48x | 1.22x | CN¥-60.49 Million |
| 2022 | 5.46% | 10.06% | 0.42x | 1.28x | CN¥-144.62 Million |
| 2023 | 7.75% | 11.66% | 0.50x | 1.33x | CN¥-75.30 Million |
| 2024 | 10.11% | 11.50% | 0.59x | 1.50x | CN¥3.59 Million |
Industry Comparison
This section compares Guangdong Marubi Biotechnology Co's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,143,263,014
- Average return on equity (ROE) among peers: 10.42%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Guangdong Marubi Biotechnology Co (603983) | CN¥3.39 Billion | 113.31% | 0.43x | $287.97 Million |
| Lonkey Industrial Co Ltd Guangzhou (000523) | $104.40 Million | 15.81% | 1.73x | $544.84 Million |
| Tianjin Yiyi Hygiene Products Co Ltd (001206) | $1.73 Billion | 6.61% | 0.14x | $227.82 Million |
| Hunan Resun Co Ltd (001218) | $905.44 Million | 24.55% | 0.67x | $278.75 Million |
| Dencare (Chongqing) Oral Care Co. Ltd. A (001328) | $542.28 Million | 24.82% | 0.88x | $209.36 Million |
| Qingdao Kingking Applied Chemistry Co Ltd (002094) | $1.92 Billion | 9.63% | 0.50x | $502.87 Million |
| C&S Paper Co Ltd (002511) | $2.28 Billion | 5.08% | 0.97x | $746.47 Million |
| Anhui Deli Household Glass Co Ltd (002571) | $1.41 Billion | -9.08% | 0.25x | $335.13 Million |
| Mingchen Health Co Ltd Class A (002919) | $739.25 Million | 3.43% | 0.68x | $467.92 Million |
| Chongqing Baiya Sanitary Products Co (003006) | $359.21 Million | 16.81% | 0.32x | $504.23 Million |
| Chengdu Rainbow Appliance Gr (003023) | $1.44 Billion | 6.57% | 0.37x | $163.63 Million |